Viewing StudyNCT00160693



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00160693
Status: COMPLETED
Last Update Posted: 2018-08-01
First Post: 2005-09-06

Brief Title: Open Label Long-Term Safety Study of Certolizumab Pegol CZP for Patients With Rheumatoid Arthritis
Sponsor: UCB Pharma
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Certolizumab Pegol CDP870 View
Rheumatoid Arthritis View
America College of Rheumatology View
Disease modifying anti-rheumatic drug View